PRJNA517185
Genome sequencing of Clostridium botulinum clinical isolates
The increasing availability of C. botulinum genome sequences is now allowing the genomic diversity of C. botulinum clinical isolates of Groups I and II to be characterised. This information will impact on microbiological food safety through improved surveillance and tracing/tracking during outbreaks, including the risk presented, and new insights into their biology, food chain transmission, and evolution.